Targeting branching in cancer therapy is an ongoing area of research. Strategies include:
Combination Therapies: Using multiple drugs simultaneously to target different subclones and reduce the likelihood of resistance. Adaptive Therapies: Adjusting treatment regimens based on the evolving genetic profile of the tumor. Immunotherapy: Leveraging the immune system to recognize and attack diverse cancer cell populations within the tumor.
